Aripiprazole
| Material: | 1 ml serum |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 100 – 350 µg/l Toxic: > 1000 µg/l |
| Please note | Aripiprazole works via an antagonism on the dopamine receptors in the CNS. Due to this, it has a sedative and antipsychotic response, whereby a higher sedative effect is combined with a lower antipsychotic effect and vice versa. It also has anticholinergic, antihistaminic, antiserotonergic and sympatholytic effect. |
| Accredited | ja |
More Results for the letter A
- Accompanying substances (BEGL)
- accompanying alcohols
- ACE (ACE)
- Angio-1 converting enzyme
- Acetone (ACET)
- Acetyl carnitine in the urine (ACECAC)
- Acetylcholine receptor antibodies (AchR)
- AchR antibodies
- ACTH (ACTH)
- Adrenocorticotropic hormone
- Actinomycosis (KACTI)
- Actinomyces spp. I
- Adenovirus infection (ADVK)
- Adrenal cortex autoantibodies (NNR)
- Adrenalin in plasma (ADRE)
- Aeromonas spp. (KAERO)
- Aeromonas hydrophilia, Aeromonas sobria, Aeromonas caviae
- AFP (AFP)
- Alpha-fetoprotein
- AGS genotyping (CYP21)
- Mutation analysis of the 21-hydroxylase gene on suspicion of adrenogenital syndrome
- Albumin in CSF (ALBL)
- Albumin in the serum (ALBUM)
- Albumin in urine (ALBUC)
- Alcohol in the blood (AETHS)
- Blood alcohol
- Aldosterone in serum (ALDO)
- Aldosterone/renin quotient (ARQ)
- Alkaline leukocyte phosphatase (ALP)
- (Alkaline neutrophil phosphatase = ANP)
- Alkaline phosphatase (AP)
- Alkaline phosphatase isoenzymes (APISO)
- bone AP, liver-biliary-bowel AP
- Alkaline phosphatase of the neutrophils (ALKA01)
- Alkaline placental phosphatase (APP)
- Regan isoenzyme
- Allergen specific IgE (ALLGENSPEZ IGE)
- Allergen specific IgG with type I reaction and hyposensitization (IGG TYP I)
- Allergen specific precipitating IgG antibodies in case of exogenous allergic alveolitis (ALVEO)
- Type III allergy
- Allergy diagnostics (ALLERGIE)
- Alpha galactosidase in leucocytes (AGALA)
- Alpha-1 antitrypsin in the serum (A1A)